Untangling the Immunological Implications of Nadir on CD4 + Cell Recovery during Suppressive Highly Active Antiretroviral Therapy
To the Editor-Moore et al. [1] recently described a significant difference in CD4 + cell recovery following HIV RNA suppression among patients receiving HAART according to nadir CD4 + cell count, with individuals whose nadir CD4 + cell counts were !200 cells/mL not achieving a protective CD4 + cell count. A lack of CD4 + cell rescue despite complete HAART-driven viremia suppression represents an everyday dilemma for HIV/ AIDS clinicians [2] . Invariably, CD4
+ cell count nadir proved to be a major and reliable determinant of suboptimal CD4 + cell recovery and clinical outcome [1] [2] [3] [4] [5] [6] [7] [8] . However, the mere quantification of CD4 + cell count nadir fails to qualitatively estimate the ultimate immunological mechanism(s) hindering CD4 + cell rescue. Only by detailing the immunological holes in nadir-driven T cell homeostasis will it be possible to devise the most efficacious treatment approach.
By limiting immune recovery assessment to total CD4 + cell count in a large patient cohort, Moore et al. [1] , although gaining statistical power, miss an insight into the immunological role of CD4 + cell count nadir. On the contrary, we feel that stringently focused studies are needed that address the time course of specific immune pathways by nadir CD4 + cell count strata. It would be interesting to know whether the authors have found distinct dynamics in immunephenotype and other immunologic parameters according to CD4 + cell count ranges. Given their major regulatory role in T cell homeostasis, common g-chain cytokines, including IL-2, IL-7, IL-15, and IL-21 [9], might be ideal markers of the direction of immune recovery. Thus, although Moore et al. [1] recommend HAART initiation at a CD4 + cell count 1350 cells/mL for the most robust immune recovery, we advocate a broad immunologic investigation of regulatory cytokine networks to obtain an indication of pretherapy immune damage and CD4 + cell rescue potential, as well as possible clinical relapses.
As an example of the exploitation of g-chain cytokine kinetics, we would like to share our experience with the IL-7 and IL-7R system [10] in a cohort of 18 antiretroviral-naive, HIV-positive patients with advanced infection (nadir CD4 + cell count, !150 cells/mL) whom we observed prospectively for the first 12 months of HAART. These patients displayed different virological and immunological responses to HAART: 12 patients had concordant responses (HIV RNA level, р50 copies/ mL; CD4 + cell count, у200 cells/mL), and 6 patients had discordant responses (HIV RNA level, р50 copies/mL; CD4 + cell count, р200 cells/mL). Despite having a higher median baseline plasma IL-7 level than that for patients with concordant responses, patients with discordant responses had a tendency toward reduced CD4 + cell count and lower IL-7Ra availability, which, by indicating free IL-7 mainly resulting from receptor downmodulation rather than compensatory production, also rules out a functional potential on T cell homeostasis. In fact, during HAART, despite a progressive reduction in IL-7, only patients with concordant responses displayed a substantial increase in CD4
+ cell and IL-7Ra expression. These findings, by clearly pointing to opposite IL-7 and IL-7R dynamics, also indicate that a lack of IL-7 and IL-7R regulatory control over CD4 + cell homeostasis could be the basis of discordant responses, which cautions against IL-7-based treatment.
In conclusion, it is time to investigate the early integration of classic quantitative determinations of CD4 + cell count nadir proposed by Moore et al. [1] with additional qualitative measures of CD4 + cell count nadir-associated immune imbalances. The effort should be to highlight the immunological role of CD4 + cell count nadir, not only as a quantitative reflection of T cell depletion, but mainly as evidence of more-complex T cell qualitative impairment. The intriguing hypothesis that a lack of IL-7-and IL-7R-mediated regulatory function is behind discordant responses in antiretroviral-naive patients with advanced infection clearly indicates the complexity of the immunopathogenetic mechanisms of CD4 + cell immune recovery. The possibility of monitoring major T cell homeostasis regulators, such as g-chain cytokines, by possibly disclosing upstream breakdown offers the appealing prospect of targeted immune interventions. Prior to the emergence of what we now know as cholera, the term "cholera" was sometimes applied to what were then considered to be various disorders traceable to disturbances of bile, including a "choleric" or angry disposition [2] . It appears to be likely that the cover illustration was intended to show treatment of that disorder, because the patient appears to be agitated, with breasts exposed, and seems to be biting a towel. There is no sign of the diarrhea, vomiting, dehydration, or collapse that are associated with what we now know as cholera.
